TransEnterix, one of the new competitors in the minimally invasive robotic surgery market, received European CE Mark approval for its Senhance Ultrasonic Instrument System. The instruments are used on the TransEnterix Senhance robitically assisted surgical system, that features haptic remote control of laparoscopic tools that let the surgeon feel what the instruments are coming in contact with, as well as 3D visualization of the internal anatomy thanks to a pair of glasses and a matching 3D capable monitor.
The ultrasonic devices are used to cut or close off different tissues, with minimal thermal effects on other tissues in the vicinity.
“Ultrasonic energy devices are critical tools in managing complex surgeries while minimizing bleeding and trauma to surrounding tissue,” said Prof. Dietmar Stephan, M.D., Head of Minimally Invasive and Robotic Surgery at St. Marien Hospitalin Siegen, Germany. “In certain procedures, use of such advanced energy has become standard of care. The addition of this capability to the Senhance Digital Laparoscopic platform is a significant expansion of clinical applicability.”